Journal article

S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: Efficacy and effects of histamine and carnitine as moderators of response

J Sarris, G I. Papakostas, O Vitolo, M Fava, D Mischoulon

Journal of Affective Disorders | ELSEVIER | Published : 2014

Abstract

Objective To assess the antidepressant efficacy of S-adenosyl methionine (SAMe), a naturally occurring methyl donor, versus the selective serotonin reuptake inhibitor (SSRI) escitalopram and a placebo control; and to determine whether serum histamine or carnitine levels modified treatment response. Methods We examined a subsample (n=144) from one site of a two-site study of adults with diagnosed Major Depressive Disorder (MDD), recruited from 4/13/05 to 12/22/09, who consented to the additional blood draw for serum histamine and carnitine levels. After washout, eligible subjects were randomized to SAMe (1600-3200 mg/daily), escitalopram (10-20 mg/daily), or matching placebo for 12 weeks of d..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Institutes of Health


Funding Acknowledgements

The parent study was supported by Grant R01AT001638-01A1 to Dr. Maurizio Fava, from the National Institutes of Health (NIH) and the National Center for Complementary and Alternative Medicine (NCCAM).Dr. Jerome Sarris was funded by a CR Roper Fellowship.Dr. David Mischoulon was funded by a Grant from the Bowman Family Foundation.